Cargando…
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
Autores principales: | Tsukune, Yutaka, Sasaki, Makoto, Odajima, Takeshi, Sunami, Kazutaka, Takei, Tomomi, Moriuchi, Yukiyoshi, Iino, Masaki, Isoda, Atsushi, Nakaya, Aya, Muta, Tsuyoshi, Miyake, Takaaki, Miyazaki, Koji, Shimizu, Takayuki, Nakajima, Kei, Igarashi, Aiko, Nagafuji, Koji, Kurihara, Taro, Aoyama, Tomonori, Sugimori, Hiroki, Komatsu, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802507/ https://www.ncbi.nlm.nih.gov/pubmed/29167420 http://dx.doi.org/10.1038/s41408-017-0002-2 |
Ejemplares similares
-
Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
por: Tsukune, Yutaka, et al.
Publicado: (2019) -
Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018) -
Bosutinib-induced lung injury: a report of two cases and literature review
por: Watanabe, Naoki, et al.
Publicado: (2022) -
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
por: Uchimura, Ayana, et al.
Publicado: (2022) -
Validity and Reliability of the Japanese Version of the Newest Vital Sign: A Preliminary Study
por: Kogure, Takamichi, et al.
Publicado: (2014)